Novel 3,3a,4,5,6,7-Hexahydroindazole and Arylthiazolylpyrazoline derivatives as Anti-inflammatory Agents

Archiv der Pharmazie

Volumn 336, Issue 12, 2003, Pages 551-559

  Nasr, Magda N A ^a   Said, Shehta A ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Anti inflammatory activity; Arylthiazolylpyrazoline; Cyclooxygenase 2 inhibitor; Hexahydroindazole

Indexed keywords

(2 THIAZOLYL) 2 PYRAZOLINE DERIVATIVE; 1 (4 FLUOROPHENYL) 2 [(4 METHYLSULFONYL)PHENYL]CYCLOPENTENE; 1 (THIAZOLO[4,5 B]QUINOXALIN 2 YL) 2 PYRAZOLINE; 1 THIOCARBAMOYL 2 PYRAZOLINE DERIVATIVE; 2 (2 THIAZOLYL) 7 BENZYLIDENE 3,3A,4,5,6,7 HEXAHYDRO 3 PHENYL 2H INDAZOLE DERIVATIVE; 5 BROMO 2 (4 FLUOROPHENYL) 3 (4 METHYLSULFONYLPHENYL)THIOPHENE; 7 BENZYLIDENE 3,3A,4,5,6,7 HEXAHYDRO 3 PHENYL 2 (THIAZOLO[4,5 B]QUINOXALIN 2 YL) 2H INDAZOLE; 7 BENZYLIDENE 3,3A,4,5,6,7 HEXAHYDRO 3 PHENYL 2 THIOCARBAMOYL 2H INDAZOLE; ALDEHYDE DERIVATIVE; ANTIINFLAMMATORY AGENT; CELECOXIB; CHLOROACETIC ACID; CYCLOOXYGENASE 2 INHIBITOR; INDOMETACIN; KETOPROFEN; PYRAZOLINE DERIVATIVE; ROFECOXIB; SODIUM HYDROXIDE; THIOSEMICARBAZIDE; TILMACOXIB; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHEMICAL REACTION; CONTROLLED STUDY; CRYSTALLIZATION; DRUG ACTIVITY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; INFRARED SPECTROSCOPY; MALE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; REACTION ANALYSIS; STEREOISOMERISM; STOMACH ULCER; ULCEROGENESIS;

ADMINISTRATION, ORAL; ANIMALS; CARRAGEENAN; CYCLOOXYGENASE INHIBITORS; EDEMA; INDAZOLES; MALE; PYRAZOLES; RATS; STRUCTURE-ACTIVITY RELATIONSHIP; TECHNOLOGY, PHARMACEUTICAL; THIAZOLES; ULCER;

EID: 0346394012     PISSN: 03656233     EISSN: None     Source Type: Journal    
DOI: 10.1002/ardp.200300796     Document Type: Article

References (50)

1. G. Lombardino, Nonsteroidal Anti-inflammatory Drugs, Wiley Interscience, John Wiley & Sons, New York, 1985.
2. D. M. Clive, J. S. Stoff, N. Engl. J. Med. 1984, 310, 563-572.
3. Y. Pirson, Y. Van, C. Persele de Stribou, Clinical Relevance. Am. J. Kidney Dis. 1986, 8, 337-344.
4. M. C. Allison, A. G. Howatson, C. J. Torramce, F. D. Russell, N. Engl. J. Med. 1992, 327, 749-754.
5. R. C. Haynes in The Pharmacological Basis of Therapeutics (Eds: A. G. Gilman, T. W. Rall, A. S. Nies, P. Taylor), 8th ed., Mc Graw-Hill, New York 1993, pp 1442-1452.
6. C. I. Bayly, W. C. Black, S. Leger, N. Quimet, M. Quellet, M. D. Percial, Bioorg. Med. Chem. Lett. 1999, 9, 307-312.
7. R. G. Kurumbail, A. M. Stevens, J. K. Gierse, J. J. McDomald, R. A. Stegerman, J. Y. Pak, D. Gildehaus, J. M. Miyashiro, T. D. Penning, K. Seibert, P. C. Isakson, W. C. Stallings, Nature 1996, 384, 644-648.
8. Y. S. Bakhle, Drugs Today 1999, 35, 237.
9. D. A. Kuyubu, B. S. Fletcher, B. C. Varnum, R. W. Lim, H. R. Schman, J. Biol. Chem. 1991, 266, 12866-12872.
10. S. H. Lee, E. Soyoola, P. Chanmugam, W. Sun, H. Zhong, S. Liou, D. Simmons, D. Hwang, J. Biol. Chem. 1992, 267, 25934-25938.
11. M. G. O. Sullivan, E. M. Huggins, C. E. McCall, Biochem. Biophys. Res. Commun. 1993, 191, 1294-1300.
12. J. L. Masferrer, B. S. Zweifel, P. T. Manning, S. D. Hauser, K. M. Leahy, W. G. Smith, P. C. Isakson, K. Seibert, Proc. Natl. Acad. Sci. USA. 1994, 91, 3228-3232.
13. T. D. Penning, J. J. Talley, S. R. Bertenshaw, J. S. Carter, RW. Collins, S. Docter, M. J. Graneto, F. J. Lee, J. W. Malecha, J. M. Miyashiro, R. S. Rogers, D. J. Rogier, S. S. Yu, G. A. Anderson, F. G. Burton, J. N. Cogburn, S. A. Gregory, C. M. Koboldt, W. E. Perkins, K. Seibert, A. W. Veenhuizen, Y. Y. Zhang, R C. Isakson, J. Med. Chem. 1997, 40, 1347-1365.
14. L. S. Simon, F. L. Lanza, P. E. Lipsky, R. C. Hubbard, S. Tolwalker, B. D. Schwarz, P. C. Isakson, G. S. Geis, Arthritis Rheum. 1998, 41, 1591-1602.
15. E. W. Ehrlich, A. Dallob, L. Lepeleive, A. Van Hecken, D. Riendeau, W. Yuan, A. Porras, J. Wittreieh, J. Seibold, P. De Sehepper, D. R. Mehliseh, B. J. Geertz, Clin. Pharmacol. Ther. 1999, 65, 336-347.
16. J. J. Talley, D. L. Brown, J. S. Carter, M. J. Graneto, C. M. Koboldt, J. L. Masfererr, W. E. Perkins, R. S. Rogers, A. F. Shaffer, Y. Y. Zhang, B. S. Zweifel, K. Seibert, J. Med. Chem. 2000, 43, 775-777.
17. JTE-522, Drugs of the future 1998, 23 (6), 598-601.
18. K. Wakitani, H. Tazaki, M. Matsushita, H. Iwamura, Inflamm. Res. 2000, 49, 117-122.
19. R. W. Friesen, D. Dubé, R. Fortin, R. Frenette, S. Prescott, W. Cromlish, G. M. Greig, S. Kargman, E. Wong, C. C. Chan, R. Gordon, L. Xu, D. Riendeau, Bioorg. Med. Chem. Lett. 1996, 6, 2677.
20. T. D. Warner, F. Giuliano, J. Vojnovie, A. Bukasa, J. A. Mitchel, J. R. Vane, Pro. Natl. Acad. Sci. USA 1999, 96, 7563-7568.
21. H. C. Huang, T. S. Chamberlain, K. Seibert, C. M. Koboldt, P. C. Isakson, D. B. Reitz, Bioorg. Med. Chem. Lett. 1995, 5, 2377.
22. G. Dannhardt, W. Kiefer, Eur. J. Med. Chem. 2001, 36, 109-126.
23. A. Palomer, F. Cabré, J. Pascual, J. Campos, M. A. Trujillo, A. Entrena, M. A. Gallo, L. Garcia, D. Mauléon, A. Espinosa, J. Med. Chem. 2002, 45, 1402-1411.
24. F. Manna, F. Chimenti, A. Bolasco, M. L. Cenicola, M. D. dAmico, C. Parrillo, F. Rossi, E. Marmo, Eur. J. Med. Chem. 1992, 27, 633-639.
25. S. M. Jain, S. Devi, S. Bani, S. Singh, G. B. Singh, Indian J. Chem. 1988, 27 B, 1019-1023.
26. A. Kumar, K. K. Saxena, S. Lata, R. S. Saxena, V. K. Srivastava, Indian Drugs 1990, 28, 111-115.
27. R. H. Udupi, S. N. Rao, A. R. Bhat, Indian J. Heterocyclic Chem. 1998, 7, 217-220.
28. S. Paul, R. Gupta, Indian J. Chem. 1998, 37 B, 1279.
29. E. Bansal, V. K. Srivastava, A. Kumar, Eur. J. Med. Chem. 2001, 36, 81-92.
30. R. A. Nugent, M. Murphy, S. T. Schlachter, C. Dunn, R. Smith, N. D. Staite, L. A. Galinet, S. K. Shields, D. G. Aspar, K. A. Richard, J. Med. Chem. 1993, 36, 134-139.
31. J. Krapcho, C. F. Turk, J. Med. Chem. 1979, 22, 207-215.
32. P. L. Warner, J. Luber, U.S. patent 1979, 4,172,647; [Chem. Abstr. 1980, 92, 58785a].
33. M. M. Gineinah, M. El-Sherbeny, M. N. Nasr, A. R. Maarouf, Arch. Pharm. Pharm. Med. Chem. 2002, 335, 556-562.
34. M. M. Gineinah, M. N. Nasr, A. M. Abdelal, A. A. El-Emam, S. A. Said, Med. Chem. Res. 2000, 10:4, 243-252.
35. G. Oszbach, D. Szabó, Acta Chim. Acad. Sci. Hung. 1975, 86, 449-456.
36. A. A. Kalaf. A. K. El-Shafei, A. M. El-Sayed, J. Heterocycl. Chem. 1982, 19, 609-612.
37. R. Jacquier, Q. Maury, Bull. Soc. Chim. Fr. 1967, 309-315.
38. T. Lóránd, D. Szabó, J. Chem. Soc. Perkin Trans. I 1985, 481-486.
39. T. Lóránd, B. Kocsis, L. Emôdy, P. Sohár, Eur. J. Med. Chem. 1999, 34, 1009-1018.
40. P. G. Farrell, B. A. Read, Can. J. Chem. 1998, 46, 3685-3692.
41. T. Lóránd, D. Szabó, A. Neszmélyi, Acta Chim. Acad. Sci. Hung. 1977, 93, 51-60.
42. P. Sohár, Nuclear Magnetic Resonance Spectroscopy, CRC Press, Boca Raton, Florida 1983, 2, 89-90.
43. H. M. Woodburn, W. E. Hoffman, J. Org. Chem. 1958, 23, 262-268.
44. S. V. Tsukermann, V. M. Nikitchenko, B. I. OstrovsKayo, V. F. Lavrushin, Ukr. Khim. Zh. 1972, 8, 2397; [Chem. Abstr. 1973, 78, 443163 j].
45. S. V. Tsukermann, V. M. Nikitchenko, B. I. OstrovsKayo, V. F. Lavrushin, Ukr. Khim. Zh. 1972, 8, 2397; [Chem. Abstr. 1973, 78, 443163 j].
46. A. F. Tolochko, M. I. Shevchuk, A. V. Domobrovskil, Zh. Org. Khim. 1972, 8, 2397; [Chem. Abstr. 1973, 78, 443163j].
47. A. F. Tolochko, M. I. Shevchuk, A. V. Domobrovskil, Zh. Org. Khim. 1972, 8, 2397; [Chem. Abstr. 1973, 78, 443163j].
48. A. C. Annigeri, S. Siddappa, Indian J. Chem. 1963, 1, 484-489.
49. C. A. Winter, E. A. Risley, G. W. Nuss, Pro. Soc. Exp. Biol. Med. 1962, 111, 544-551.
50. E. Adami, E. Marazzi-Uberti, C. Tuba, Arch. Intern. Pharmacodyn. 1964, 117, 113-121.